Sun C, Sun H, Wei J, Fan X, Simon S, Passerini A
Inflammation. 2024; .
PMID: 39641858
DOI: 10.1007/s10753-024-02209-w.
Peel J, Owiredu E, Rosenberg A, Silva-Sanchez A, Randall T, Kearney J
J Immunol. 2024; 213(12):1771-1786.
PMID: 39451043
PMC: 11611650.
DOI: 10.4049/jimmunol.2300575.
Wang L, Xie T, Zhou X, Yang G, Guo Z, Huang Y
3 Biotech. 2023; 13(11):367.
PMID: 37846216
PMC: 10576694.
DOI: 10.1007/s13205-023-03773-y.
Thouenon R, Kracker S
Front Immunol. 2023; 14:1236889.
PMID: 37809068
PMC: 10556498.
DOI: 10.3389/fimmu.2023.1236889.
Bi X, Mills T, Wu M
Curr Opin Rheumatol. 2023; 35(6):364-370.
PMID: 37605874
PMC: 10553484.
DOI: 10.1097/BOR.0000000000000967.
Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection.
Duncan J, Xu D, Licursi M, Joyce M, Saffran H, Liu K
Front Immunol. 2023; 14:930086.
PMID: 37197656
PMC: 10183588.
DOI: 10.3389/fimmu.2023.930086.
Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest.
Rossi M, Anerillas C, Idda M, Munk R, Shin C, Donega S
Elife. 2023; 12.
PMID: 37083495
PMC: 10121226.
DOI: 10.7554/eLife.84238.
Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction.
Zhao J, Yuan X, Luo R, Wang L, Gu W, Yamane D
Front Immunol. 2023; 14:1107239.
PMID: 37063830
PMC: 10102619.
DOI: 10.3389/fimmu.2023.1107239.
Functional characterization of goose IRF1 in IFN induction and anti-NDV infection.
Lin Z, Wang J, Zhang N, Yi J, Wang Z, Ma J
Vet Res. 2022; 53(1):29.
PMID: 35379320
PMC: 8981851.
DOI: 10.1186/s13567-022-01046-9.
Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia.
Palmroth M, Viskari H, Seppanen M, Keskitalo S, Virtanen A, Varjosalo M
Pharmaceuticals (Basel). 2021; 14(8).
PMID: 34451894
PMC: 8402006.
DOI: 10.3390/ph14080797.
Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms.
Verzosa A, McGeever L, Bhark S, Delgado T, Salazar N, Sanchez E
Front Immunol. 2021; 12:644664.
PMID: 34135889
PMC: 8201405.
DOI: 10.3389/fimmu.2021.644664.
IRF1 governs the differential interferon-stimulated gene responses in human monocytes and macrophages by regulating chromatin accessibility.
Song R, Gao Y, Dozmorov I, Malladi V, Saha I, McDaniel M
Cell Rep. 2021; 34(12):108891.
PMID: 33761354
PMC: 8300000.
DOI: 10.1016/j.celrep.2021.108891.
Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses.
Feng H, Zhang Y, Gui J, Lemon S, Yamane D
PLoS Pathog. 2021; 17(1):e1009220.
PMID: 33476326
PMC: 7819612.
DOI: 10.1371/journal.ppat.1009220.
IRF-1 contributes to the pathological phenotype of VSMCs during atherogenesis by increasing CCL19 transcription.
Shen Y, Sun Z, Mao S, Zhang Y, Jiang W, Wang H
Aging (Albany NY). 2021; 13(1):933-943.
PMID: 33424012
PMC: 7835033.
DOI: 10.18632/aging.202204.
IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.
Rho S, Lee S, Byun H, Kim B, Lee C
Int J Mol Sci. 2020; 21(20).
PMID: 33076322
PMC: 7589982.
DOI: 10.3390/ijms21207622.
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication.
Maddaluno L, Urwyler C, Rauschendorfer T, Meyer M, Stefanova D, Sporri R
EMBO Mol Med. 2020; 12(9):e11793.
PMID: 32720440
PMC: 7507082.
DOI: 10.15252/emmm.201911793.
Of Keeping and Tipping the Balance: Host Regulation and Viral Modulation of IRF3-Dependent Expression.
Schwanke H, Stempel M, Brinkmann M
Viruses. 2020; 12(7).
PMID: 32645843
PMC: 7411613.
DOI: 10.3390/v12070733.
IRF1 Negatively Regulates Oncogenic KPNA2 Expression Under Growth Stimulation and Hypoxia in Lung Cancer Cells.
Huang J, Wu Y, Cheng Y, Wang C, Yu C
Onco Targets Ther. 2020; 12:11475-11486.
PMID: 31920336
PMC: 6939401.
DOI: 10.2147/OTT.S221832.
TRIM14 expression is regulated by IRF-1 and IRF-2.
Cui J, Xu X, Li Y, Hu X, Xie Y, Tan J
FEBS Open Bio. 2019; 9(8):1413-1420.
PMID: 31150153
PMC: 6668374.
DOI: 10.1002/2211-5463.12682.
: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections.
Smith J, Mathew L, Gaikwad A, Rech B, Burney M, Faro J
Front Oncol. 2019; 9:173.
PMID: 30949451
PMC: 6435520.
DOI: 10.3389/fonc.2019.00173.